Zobrazeno 1 - 10
of 33
pro vyhledávání: '"Philip J. Provost"'
Autor:
Philip J. Provost, Ira Chalikonda, Stanley M. Lemon, Timothy L. Schofield, Joseph P. Davide, Paula C. Murphy, David R. Nalin, John A. Lewis
Publikováno v:
The Journal of Infectious Diseases. 176:9-19
Antibodies to hepatitis A virus (anti-HAV) were measured in children from two separate vaccine trials (n = 70) 4 weeks after a dose of inactivated hepatitis A vaccine (VAQTA). The geometric mean titers (GMTs) of anti-HAV were 49.3 and 45.2 mIU/mL by
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7d767da1ae69105fdf6cab50aeb4572a
https://doi.org/10.1086/514044
https://doi.org/10.1086/514044
Publikováno v:
Journal of Virological Methods. 53:176-187
An enhanced neutralization assay was developed to permit the sensitive, specific, and reproducible measurement of antibodies to varicella-zoster virus (VZV). Optimal neutralization was achieved using a combination of guinea pig complement (C') and ra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::216caddd68e372196f60a3993adc4b3c
https://doi.org/10.1016/0166-0934(95)00013-k
https://doi.org/10.1016/0166-0934(95)00013-k
Autor:
Gary B. Calandra, David R. Nalin, Philip J. Provost, Edward F. Ellerbeck, Audrey E. Rhoad, John A. Lewis, Brenda McGuire, Kenneth Gershman, K Midthun, William J. Miller, Joseph P. Davide, Marcy E. Armstrong
Publikováno v:
Vaccine. 10:668-672
To determine the safety and immunogenicity of an inactivated hepatitis A vaccine, 56 healthy adult volunteers were randomly assigned to receive an intramuscular injection of 6.3, 12.5 or 25 ng of inactivated hepatitis A vaccine or placebo at 0, 2 or
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4860bd5a5e959ab54418e5820ce41496
https://doi.org/10.1016/0264-410x(92)90087-z
https://doi.org/10.1016/0264-410x(92)90087-z
Publikováno v:
Journal of Medical Virology. 34:227-231
Live, attenuated F' hepatitis A vaccine virus was studied in vivo in Saguinus labiatus marmosets for possible reversion to virulence, for possible establishment of persistent infection and for its capacity as a parenterally administered vaccine to in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::36d120593a9653899ca7b46003b003b9
https://doi.org/10.1002/jmv.1890340406
https://doi.org/10.1002/jmv.1890340406
Autor:
Barbara J. Kuter, Robert D. Sitrin, Gary B. Calandra, Stanley L. Block, Alan Werzberger, Robert Bishop, Edward F. Ellerbeck, Leora Brown, Philip J. Provost, Daniel Shouval, William J. Miller, David R. Nalin, John A. Lewis, Skai W. Schwartz, Brian L. Wiens, John L. Ryan, Carol Patterson
Publikováno v:
Journal of hepatology. 18
The worldwide experience to date with VAQTA TM , a highly purified formalin-inactivated hepatitis A vaccine containing alum-adjuvant, is reviewed. No serious adverse experience related to vaccination has been reported. The vaccine has proven highly i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d5fb07c077443531716b82aa7a019c04
https://pubmed.ncbi.nlm.nih.gov/8182275
https://pubmed.ncbi.nlm.nih.gov/8182275
Autor:
Brian L. Wiens, Daniel Shouval, Philip J. Provost, Robert D. Sitrin, Alan Werzberger, Barbara J. Kuter, Barbara Mensch, David R. Nalin, Leora Brown, William J. Miller, John A. Lewis
Publikováno v:
Journal of hepatology. 18
The performance of vaccine protective efficacy trials is often more complex than reports of final results suggest. The current article reviews the background, planning and preparations for the Monroe, NY, protective efficacy trial of a formalin-inact
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cff301feb19ac808b9078a1a7498c269
https://pubmed.ncbi.nlm.nih.gov/8182273
https://pubmed.ncbi.nlm.nih.gov/8182273
Autor:
Beverly J. Neff, Barbara A. Watson, Robert E. Weibel, Philip J. Provost, David H. Morton, Holly Matthews, Stanley A. Plotkin, Barbara J. Kuter, Stuart E. Starr, Harry A. Guess
Publikováno v:
Vaccine. 9(9)
A large double-blind, randomized, placebo-controlled trial of live attenuated Oka/Merck varicella vaccine was conducted among healthy children, 1-14 years of age. During the first varicella season, the efficacy of the vaccine among susceptible childr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4f103886f329684d657c8ee47578fe6a
https://pubmed.ncbi.nlm.nih.gov/1659052
https://pubmed.ncbi.nlm.nih.gov/1659052
A simple antigen-reduction assay for the measurement of neutralizing antibodies to hepatitis A virus
Publikováno v:
The Journal of infectious diseases. 163(3)
A simplified hepatitis A virus (HAV) antigen-reduction neutralization assay (HAVARNA) was developed to permit the measurement of biologically active antibodies in recipients of candidate HAV vaccines. Degrees of neutralization were measured from the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0724184b2eea8b578e949a3c6ac73f2a
https://pubmed.ncbi.nlm.nih.gov/1847404
https://pubmed.ncbi.nlm.nih.gov/1847404
Autor:
Timothy L. Schofield, E H Wasmuth, Barbara J. Kuter, David L. Krah, Philip J. Provost, William J. Miller, D H Morton, Ronald W. Ellis, C J White
Publikováno v:
Vaccine. 9(2)
An enzyme-linked immunosorbent assay for antibodies to varicella-zoster virus (VZV), using purified viral glycoproteins as antigen (gpELISA), was compared with other assays for measuring vaccine-induced antibody responses. The gpELISA was more sensit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::14b75334610a2bf3e7b01d019ff48733
https://pubmed.ncbi.nlm.nih.gov/1647574
https://pubmed.ncbi.nlm.nih.gov/1647574
Publikováno v:
Journal of virological methods. 27(3)
The infectivity titers of varicella-zoster virus (VZV) are routinely estimated by plaque production in cell culture. In this report, we show that plaque counts for VZV (strain Oka/Merck), in MRC-5 cell cultures, are significantly enhanced (54% averag
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::03be3f3c80fd090986c6289ed44b2e75
https://pubmed.ncbi.nlm.nih.gov/2157731
https://pubmed.ncbi.nlm.nih.gov/2157731